Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $999546.0.

  • iSpecimen's Capital Expenditures rose 61189.69% to $999546.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 6124.06%. This contributed to the annual value of $653288.0 for FY2024, which is 8265.91% down from last year.
  • iSpecimen's Capital Expenditures amounted to $999546.0 in Q3 2025, which was up 61189.69% from $65195.0 recorded in Q4 2024.
  • iSpecimen's Capital Expenditures' 5-year high stood at $1.5 million during Q1 2023, with a 5-year trough of $65195.0 in Q4 2024.
  • Its 5-year average for Capital Expenditures is $554777.6, with a median of $304195.0 in 2021.
  • In the last 5 years, iSpecimen's Capital Expenditures plummeted by 8555.31% in 2024 and then skyrocketed by 61189.69% in 2025.
  • Over the past 5 years, iSpecimen's Capital Expenditures (Quarter) stood at $304195.0 in 2021, then skyrocketed by 368.91% to $1.4 million in 2022, then tumbled by 81.34% to $266126.0 in 2023, then crashed by 75.5% to $65195.0 in 2024, then surged by 1433.16% to $999546.0 in 2025.
  • Its Capital Expenditures was $999546.0 in Q3 2025, compared to $65195.0 in Q4 2024 and $140406.0 in Q3 2024.